https://orcid.org/0000-0001-9690-8555
References
- Swerdlow SH, Campo E, Pileri SA, et al. The 2016 revision of the World Health Organization classification of lymphoid neoplasms. Blood. 2016;127(20):2375–2390. doi:10.1182/blood-2016-01-643569
- Ponzoni M, Campo E, Nakamura S. Intravascular large B-cell lymphoma: a chameleon with multiple faces and many masks. Blood. 2018;132(15):1561–1567. doi:10.1182/blood-2017-04-737445
- Fonkem E, Dayawansa S, Stroberg E, et al. Neurological presentations of intravascular lymphoma (IVL): meta-analysis of 654 patients. BMC Neurol. 2016;16(1):9. doi:10.1186/s12883-015-0509-8
- Yamamoto A, Kikuchi Y, Homma K, et al. Characteristics of intravascular large B-cell lymphoma on cerebral MR imaging. AJNR Am J Neuroradiol. 2012;33(2):292–296. doi:10.3174/ajnr.A2770
- Abe Y, Narita K, Kobayashi H, et al. Clinical value of abnormal findings on brain magnetic resonance imaging in patients with intravascular large B-cell lymphoma. Ann Hematol. 2018;97(12):2345–2352. doi:10.1007/s00277-018-3481-8
- Williams RL, Meltzer CC, Smirniotopoulos JG, et al. Cerebral MR imaging in intravascular lymphomatosis. AJNR Am J Neuroradiol. 1998;19:427–431.
- Calabrese LH, Dodick DW, Schwedt TJ, et al. Narrative review: reversible cerebral vasoconstriction syndromes. Ann Intern Med. 2007;146(1):34–44. doi:10.7326/0003-4819-146-1-200701020-00007
- Ducros A, Boukobza M, Porcher R, et al. The clinical and radiological spectrum of reversible cerebral vasoconstriction syndrome. A prospective series of 67 patients. Brain. 2007;130(Pt 12):3091–3101. doi:10.1093/brain/awm256
- Singhal AB, Hajj-Ali RA, Topcuoglu MA, et al. Reversible cerebral vasoconstriction syndromes: analysis of 139 cases. Arch Neurol. 2011;68(8):1005–1012. doi:10.1001/archneurol.2011.68
- Wang X, Zhang Y, You H, et al. A case of reversible cerebral vasoconstriction syndrome triggered by high-dose methotrexate in a boy with lymphoma. Headache. 2020;60(8):1767–1772. doi:10.1111/head.13526
- Sankhe S, Kamath N, Sahu A. A rare case of chemotherapy induced reversible cerebral vasoconstriction syndrome in a patient of acute lymphocytic leukemia. J Cancer Res Ther. 2015;11(4):1012–1014. doi:10.4103/0973-1482.168993
- Mendes NT, Ramos de Freitas L, Lopes RP, et al. Reversible cerebral vasoconstriction syndrome after intrathecal cytarabine. Hematol Transfus Cell Ther. 2022;44(3):422–425. doi:10.1016/j.htct.2020.10.961
- Chen SP, Wang SJ. Pathophysiology of reversible cerebral vasoconstriction syndrome. J Biomed Sci. 2022;29(1):72. doi:10.1186/s12929-022-00857-4
- Fugate JE, Rabinstein AA. Posterior reversible encephalopathy syndrome: clinical and radiological manifestations, pathophysiology, and outstanding questions. Lancet Neurol. 2015;14(9):914–925. doi:10.1016/S1474-4422(15)00111-8
- Jeanneret V, Jillella DV, Rangaraju S, et al. PRES and RCVS: two distinct entities or a spectrum of the same disease? J Stroke Cerebrovasc Dis. 2022;31(6):106472. doi:10.1016/j.jstrokecerebrovasdis.2022.106472